StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.17+0.02 (+0.39%)

Close on Nov 18, 2026Market cap $280.03MP/E –Yield –

Eikon Therapeutics cash

Cash and short-term investments held at the end of each period.

Eikon Therapeutics's cash was $531.18M at Jun 30, 2026. For fiscal 2025 it was $335.98M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$335.98M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$531.18M+159.6%
Q1 FY2026Mar 31, 2026$512.18M–
Q4 FY2025Dec 31, 2025$335.98M–
Q2 FY2025Jun 30, 2025$136.56M–
Q1 FY2025Mar 31, 2025$204.58M–

More Eikon Therapeutics figures

See a number that looks wrong?